Monday, May 27, 2019

FOX BIZ NEWS: Can Novartis Convince Insurers a $2.1 Million Gene Therapy Is a Great Deal?


Can Novartis Convince Insurers a $2.1 Million Gene Therapy Is a Great Deal?



Getting end payers on board with a seven-figure price for Zolgensma won't be easy.

via FOX BUSINESS NEWS https://fxn.ws/2JG0JFN
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)